Chest Pain in a 42-Year-Old with a 'Normal' ECG
A 42-year-old man presents to your clinic 3 hours after central chest pressure that began while carrying shopping and eased after 10 minutes of rest. He has had two similar episodes this week. He smokes 20/day, has a BMI of 31, and his father had a myocardial infarction at 55. He is now pain-free. BP 138/86, pulse 82 regular, chest clear, no leg swelling. Your clinic has a 12-lead ECG machine; the tracing shows sinus rhythm with T-wave flattening in leads V4–V6 but no ST elevation. Troponin is not available in your clinic and the nearest emergency department is 25 minutes away. He says: 'I'm fine now - can't you just give me a spray and a cholesterol tablet?'
1. What is your working diagnosis and immediate disposition, and why is 'normal ECG, pain-free now' not reassuring here?
Read the worked answer
Working diagnosis: unstable angina / non-ST-elevation acute coronary syndrome (NSTE-ACS) until proven otherwise. The features that make this high-risk are the classic triad of exertional central pressure, relief with rest, and a crescendo pattern (two episodes in a week) in a man with multiple risk factors.
Disposition: same-day urgent transfer to an emergency department for serial high-sensitivity troponin and further risk stratification - not routine outpatient referral.
Why 'normal ECG' is not reassuring:
- A resting ECG between episodes is frequently normal or non-specific in NSTE-ACS; T-wave flattening in V4–V6 is itself an ischaemic change.
- Normal ECG does not exclude unstable angina or a later rise in troponin; the diagnosis is clinical plus serial biomarkers.
- The pain-free state reflects the episodic nature of plaque instability, not resolution of risk.
Practical steps: give aspirin 300 mg chewed (unless contraindicated) and a single sublingual nitrate with caution if no right-ventricular involvement/hypotension, arrange safe transport (ambulance or accompanied, not self-driving), document ECG time and findings, and send a referral letter. Do not send him home with a 'GTN spray and statin' as the sole plan.
2. He asks why he can't just have an exercise stress test at the hospital next week. Explain the role of the ECG and of troponin in his situation, and why timing matters.
Read the worked answer
Troponin: high-sensitivity troponin measured serially (typically at presentation and 1–3 hours) is the test that detects myocardial injury and drives the rule-out/rule-in pathway for NSTE-ACS. A single early value in a clinic without serial testing cannot exclude ACS.
Exercise stress testing: it is a test for stable chest pain in patients at low/intermediate risk after ACS has been excluded. It is the wrong test for someone with a crescendo pattern and possible unstable angina - exercising a patient with an unstable plaque is potentially harmful, and a 'negative' stress test would falsely reassure. In unstable presentations, the pathway is troponin plus risk stratification, and further testing (e.g. CT coronary angiography or functional imaging) is arranged by the secondary care team once ACS is excluded.
Why timing matters: the window for detecting injury and for early revascularisation in high-risk NSTE-ACS is hours to days. Delay allows progression to infarction, arrhythmia or sudden death. Explain this to him in plain terms: 'Your symptoms fit a blocked artery that is unstable now; the tests need to happen today, not next week.'
3. Assuming ACS is excluded and he is discharged from hospital, outline the secondary-prevention package you would start or reinforce in primary care, including targets.
Read the worked answer
Secondary prevention package
- Smoking: brief advice plus referral to cessation support; offer pharmacotherapy (varenicline or NRT combination) - the single highest-yield intervention.
- Antiplatelet: aspirin 75 mg long term if coronary disease confirmed; if a stent is placed, follow the cardiologist's DAPT duration - do not alter it independently.
- Statin: high-intensity (e.g. atorvastatin 80 mg) aiming for LDL <1.4 mmol/L; recheck lipids at 8–12 weeks and titrate/escalate if not at target.
- Antihypertensive/antianginal therapy: per cardiology; ensure BP <130/80 where tolerated.
- Diabetes screening: HbA1c and fasting glucose if not already done.
- Cardiac rehabilitation: refer - improves mortality, function and adherence.
- Weight and activity: structured exercise, dietitian input for BMI 31; aim for 150 min/week moderate activity once cleared.
- Adherence and review: explain each drug's purpose, use a pill organizer if needed, review at 4–6 weeks and annually; check for statin myopathy and bleeding.
- Family: discuss risk in first-degree relatives and their own risk assessment.